51 related articles for article (PubMed ID: 38432677)
41. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
42. Precancerous lesions of intrahepatic cholangiocarcinoma.
Shimonishi T; Sasaki M; Nakanuma Y
J Hepatobiliary Pancreat Surg; 2000; 7(6):542-50. PubMed ID: 11180885
[TBL] [Abstract][Full Text] [Related]
43. Management and extent of resection for intrahepatic cholangiocarcinoma.
Carpizo DR; D'Angelica M
Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813
[TBL] [Abstract][Full Text] [Related]
44. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
45. Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges.
Jabri A; Khan J; Taftafa B; Alsharif M; Mhannayeh A; Chinnappan R; Alzhrani A; Kazmi S; Mir MS; Alsaud AW; Yaqinuddin A; Assiri AM; AlKattan K; Vashist YK; Broering DC; Mir TA
Bioengineering (Basel); 2024 Apr; 11(4):. PubMed ID: 38671768
[TBL] [Abstract][Full Text] [Related]
46. Promising preclinical models for lung cancer research-lung cancer organoids: a narrative review.
Chen X; Ye L; Wang H; Liu X; Zhao L; Xu K; Liu Y; He Y
Transl Lung Cancer Res; 2024 Mar; 13(3):623-634. PubMed ID: 38601435
[TBL] [Abstract][Full Text] [Related]
47. [Establishment and application of intrahepatic cholangiocarcinoma organoid models].
Liu Y; Liang X
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):346-352. PubMed ID: 38432677
[TBL] [Abstract][Full Text] [Related]
48. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.
De Siervi S; Turato C
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901961
[TBL] [Abstract][Full Text] [Related]
49. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.
Sato K; Zhang W; Safarikia S; Isidan A; Chen AM; Li P; Francis H; Kennedy L; Baiocchi L; Alvaro D; Glaser S; Ekser B; Alpini G
Hepatology; 2021 Jul; 74(1):491-502. PubMed ID: 33222247
[TBL] [Abstract][Full Text] [Related]
50. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
51. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids.
Amato F; Rae C; Prete MG; Braconi C
Cells; 2020 Mar; 9(4):. PubMed ID: 32235647
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
